Cargando…

Alveolar nitric oxide and its role in pediatric asthma control assessment

BACKGROUND: Nitric oxide can be measured at multiple flow rates to determine proximal (maximum airway nitric oxide flux; Jaw(NO)) and distal inflammation (alveolar nitric oxide concentration; CA(NO)). The main aim was to study the association among symptoms, lung function, proximal (maximum airway n...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardón, Olaia, Corcuera, Paula, Aldasoro, Ane, Korta, Javier, Mintegui, Javier, Emparanza, José I, Pérez-Yarza, Eduardo G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124482/
https://www.ncbi.nlm.nih.gov/pubmed/25090994
http://dx.doi.org/10.1186/1471-2466-14-126
_version_ 1782329625391661056
author Sardón, Olaia
Corcuera, Paula
Aldasoro, Ane
Korta, Javier
Mintegui, Javier
Emparanza, José I
Pérez-Yarza, Eduardo G
author_facet Sardón, Olaia
Corcuera, Paula
Aldasoro, Ane
Korta, Javier
Mintegui, Javier
Emparanza, José I
Pérez-Yarza, Eduardo G
author_sort Sardón, Olaia
collection PubMed
description BACKGROUND: Nitric oxide can be measured at multiple flow rates to determine proximal (maximum airway nitric oxide flux; Jaw(NO)) and distal inflammation (alveolar nitric oxide concentration; CA(NO)). The main aim was to study the association among symptoms, lung function, proximal (maximum airway nitric oxide flux) and distal (alveolar nitric oxide concentration) airway inflammation in asthmatic children treated and not treated with inhaled glucocorticoids. METHODS: A cross-sectional study with prospective data collection was carried out in a consecutive sample of girls and boys aged between 6 and 16 years with a medical diagnosis of asthma. Maximum airway nitric oxide flux and alveolar nitric oxide concentration were calculated according to the two-compartment model. In asthmatic patients, the asthma control questionnaire (CAN) was completed and forced spirometry was performed. In controls, differences between the sexes in alveolar nitric oxide concentration and maximum airway nitric oxide flux and their correlation with height were studied. The correlation among the fraction of exhaled NO at 50 ml/s (FE(NO50)), CA(NO), Jaw(NO), forced expiratory volume in 1 second (FEV(1)) and the CAN questionnaire was measured and the degree of agreement regarding asthma control assessment was studied using Cohen’s kappa. RESULTS: We studied 162 children; 49 healthy (group 1), 23 asthmatic participants without treatment (group 2) and 80 asthmatic patients treated with inhaled corticosteroids (group 3). CA(NO) (ppb) was 2.2 (0.1-4.5), 3 (0.2-9.2) and 2.45 (0.1-24), respectively. Jaw(NO) (pl/s) was 516 (98.3-1470), 2356.67 (120–6110) and 1426 (156–11805), respectively. There was a strong association (r = 0.97) between FE(NO50) and Jaw(NO) and the degree of agreement was very good in group 2 and was good in group 3. There was no agreement or only slight agreement between the measures used to monitor asthma control (FEV(1), CAN questionnaire, CA(NO) and Jaw(NO)). CONCLUSIONS: The results for CA(NO) and Jaw(NO) in controls were similar to those found in other reports. There was no agreement or only slight agreement among the three measure instruments analyzed to assess asthma control. In our sample, no additional information was provided by CA(NO) and Jaw(NO).
format Online
Article
Text
id pubmed-4124482
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41244822014-08-08 Alveolar nitric oxide and its role in pediatric asthma control assessment Sardón, Olaia Corcuera, Paula Aldasoro, Ane Korta, Javier Mintegui, Javier Emparanza, José I Pérez-Yarza, Eduardo G BMC Pulm Med Research Article BACKGROUND: Nitric oxide can be measured at multiple flow rates to determine proximal (maximum airway nitric oxide flux; Jaw(NO)) and distal inflammation (alveolar nitric oxide concentration; CA(NO)). The main aim was to study the association among symptoms, lung function, proximal (maximum airway nitric oxide flux) and distal (alveolar nitric oxide concentration) airway inflammation in asthmatic children treated and not treated with inhaled glucocorticoids. METHODS: A cross-sectional study with prospective data collection was carried out in a consecutive sample of girls and boys aged between 6 and 16 years with a medical diagnosis of asthma. Maximum airway nitric oxide flux and alveolar nitric oxide concentration were calculated according to the two-compartment model. In asthmatic patients, the asthma control questionnaire (CAN) was completed and forced spirometry was performed. In controls, differences between the sexes in alveolar nitric oxide concentration and maximum airway nitric oxide flux and their correlation with height were studied. The correlation among the fraction of exhaled NO at 50 ml/s (FE(NO50)), CA(NO), Jaw(NO), forced expiratory volume in 1 second (FEV(1)) and the CAN questionnaire was measured and the degree of agreement regarding asthma control assessment was studied using Cohen’s kappa. RESULTS: We studied 162 children; 49 healthy (group 1), 23 asthmatic participants without treatment (group 2) and 80 asthmatic patients treated with inhaled corticosteroids (group 3). CA(NO) (ppb) was 2.2 (0.1-4.5), 3 (0.2-9.2) and 2.45 (0.1-24), respectively. Jaw(NO) (pl/s) was 516 (98.3-1470), 2356.67 (120–6110) and 1426 (156–11805), respectively. There was a strong association (r = 0.97) between FE(NO50) and Jaw(NO) and the degree of agreement was very good in group 2 and was good in group 3. There was no agreement or only slight agreement between the measures used to monitor asthma control (FEV(1), CAN questionnaire, CA(NO) and Jaw(NO)). CONCLUSIONS: The results for CA(NO) and Jaw(NO) in controls were similar to those found in other reports. There was no agreement or only slight agreement among the three measure instruments analyzed to assess asthma control. In our sample, no additional information was provided by CA(NO) and Jaw(NO). BioMed Central 2014-08-04 /pmc/articles/PMC4124482/ /pubmed/25090994 http://dx.doi.org/10.1186/1471-2466-14-126 Text en Copyright © 2014 Sardón et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sardón, Olaia
Corcuera, Paula
Aldasoro, Ane
Korta, Javier
Mintegui, Javier
Emparanza, José I
Pérez-Yarza, Eduardo G
Alveolar nitric oxide and its role in pediatric asthma control assessment
title Alveolar nitric oxide and its role in pediatric asthma control assessment
title_full Alveolar nitric oxide and its role in pediatric asthma control assessment
title_fullStr Alveolar nitric oxide and its role in pediatric asthma control assessment
title_full_unstemmed Alveolar nitric oxide and its role in pediatric asthma control assessment
title_short Alveolar nitric oxide and its role in pediatric asthma control assessment
title_sort alveolar nitric oxide and its role in pediatric asthma control assessment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124482/
https://www.ncbi.nlm.nih.gov/pubmed/25090994
http://dx.doi.org/10.1186/1471-2466-14-126
work_keys_str_mv AT sardonolaia alveolarnitricoxideanditsroleinpediatricasthmacontrolassessment
AT corcuerapaula alveolarnitricoxideanditsroleinpediatricasthmacontrolassessment
AT aldasoroane alveolarnitricoxideanditsroleinpediatricasthmacontrolassessment
AT kortajavier alveolarnitricoxideanditsroleinpediatricasthmacontrolassessment
AT minteguijavier alveolarnitricoxideanditsroleinpediatricasthmacontrolassessment
AT emparanzajosei alveolarnitricoxideanditsroleinpediatricasthmacontrolassessment
AT perezyarzaeduardog alveolarnitricoxideanditsroleinpediatricasthmacontrolassessment